Skip to content

ESLAW ESTRELLA IMMUNOPHARMA INC

Follow

SPAC Combination (warrant or right), issuer CIK 1844417

Filings received so far for Q3 2026: 7 13F filers report a position in ESLAW shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
BOOTHBAY FUND MANAGEMENT, LLC189,899$12.6K<0.01%013F-HRTimeline
Robertson Stephens Wealth Management, L…12,000$5.6K<0.01%013F-HRTimeline
D. E. Shaw & Co., Inc.in group D. E. Shaw & Co., Inc.87,500$5.26K<0.01%013F-HRTimelineGroup
Yakira Capital Management, Inc.in group Yakira Capital Management, In…46,285$2.78K<0.01%013F-HRTimelineGroup
WHITEBOX ADVISORS LLC42,293$2.54K<0.01%013F-HRTimeline
Clear Street Group Inc.in group Clear Street Group Inc.34,082$2.04K<0.01%013F-HRTimelineGroup
TORONTO DOMINION BANKin group TORONTO DOMINION BANK21,635$1.3K<0.01%013F-HRTimelineGroup